Compare XYL & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XYL | STE |
|---|---|---|
| Founded | 2011 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Fluid Controls | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.0B | 21.3B |
| IPO Year | 2011 | 2018 |
| Metric | XYL | STE |
|---|---|---|
| Price | $104.06 | $208.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 9 |
| Target Price | $153.88 | ★ $263.13 |
| AVG Volume (30 Days) | ★ 2.3M | 549.2K |
| Earning Date | 10-27-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.68% | 1.31% |
| EPS Growth | 7.40 | ★ 27.90 |
| EPS | 1.90 | ★ 7.93 |
| Revenue | ★ $9,035,000,000.00 | $5,935,900,000.00 |
| Revenue This Year | $1.89 | $7.35 |
| Revenue Next Year | $4.61 | $6.36 |
| P/E Ratio | $53.99 | ★ $26.66 |
| Revenue Growth | 5.52 | ★ 8.73 |
| 52 Week Low | $98.58 | $195.14 |
| 52 Week High | $154.27 | $269.44 |
| Indicator | XYL | STE |
|---|---|---|
| Relative Strength Index (RSI) | 41.97 | 36.90 |
| Support Level | N/A | $208.29 |
| Resistance Level | $125.73 | $220.39 |
| Average True Range (ATR) | 2.43 | 3.70 |
| MACD | 0.06 | 0.61 |
| Stochastic Oscillator | 48.93 | 51.50 |
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.